Similar articles

• [Prognostic factors in malignant glioma in elderly patients].

  Nishihara M, Taomoto K, Kohmura E. Nishihara M, et al. Nihon Rinsho. 2005 Sep;63 Suppl 9:596-9. Nihon Rinsho. 2005. PMID: 16201587 Review. Japanese. No abstract available.
• Brainstem gliomas.

  Packer RJ, Nicholson HS, Vezina LG, Johnson DL. Packer RJ, et al. Neurosurg Clin N Am. 1992 Oct;3(4):863-79. Neurosurg Clin N Am. 1992. PMID: 1392581 Review.
• [Treatment for low grade glioma focusing on grade II glioma].

  Kayama T, Mouri W, Sakurada K, Sato S. Kayama T, et al. No To Shinkei. 2005 Dec;57(12):1035-42. No To Shinkei. 2005. PMID: 16375188 Review. Japanese. No abstract available.
• [Latest treatment strategies for malignant gliomas].

  Shono T, Mizoguchi M, Sasaki T. Shono T, et al. Fukuoka Igaku Zasshi. 2007 Sep;98(9):333-6. Fukuoka Igaku Zasshi. 2007. PMID: 17974076 Review. Japanese. No abstract available.
• Management of patients with low-grade gliomas.

  Gilbert MR, Lang FF. Gilbert MR, et al. Neurol Clin. 2007 Nov;25(4):1073-88, ix. doi: 10.1016/j.ncl.2007.07.007. Neurol Clin. 2007. PMID: 17964026 Review.